This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Pfizer CEO says proposed AstraZeneca bid wouldn't face antitrust problems

By Matthew Newman ( May 13, 2014, 10:17 GMT | Insight) -- Pfizer Chief Execuitive Ian Read told UK politicians today that a proposed bid for AstraZeneca wouldn't face antitrust problems anywhere in the world. New York-based Pfizer is seeking to overcome concerns that the bid will lead to cuts in research jobs in the UK so it can move forward to create the world’s largest pharmaceutical company.Pfizer Chief Execuitive Ian Read told UK politicians today that a proposed bid for AstraZeneca wouldn't face antitrust problems anywhere in the world....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login